Wagner Paul A. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-08-15 5:15 pm Purchase | 2023-07-31 | 13D | Forte Biosciences, Inc. FBRX | Wagner Paul A. | 76,048 5.210% | 24,886![]() (+48.64%) | Filing |
2021-09-16 4:05 pm Sale | 2021-09-07 | 13D | Forte Biosciences, Inc. FBRX | Wagner Paul A. | 51,162 9.100% | -39,720![]() (-43.71%) | Filing |
2020-06-25 4:16 pm Purchase | 2020-06-15 | 13D | Forte Biosciences, Inc. FBRX | Wagner Paul A. | 90,882 21.040% | 90,882![]() (New Position) | Filing |